These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Parasympathetic non-adrenergic, non-cholinergic transmission in rat parotid glands: effects of cholecystokinin-A and -B receptor antagonists on the secretory response. Ekström J, Cevik Aras H. Regul Pept; 2008 Feb 07; 146(1-3):278-84. PubMed ID: 18006087 [Abstract] [Full Text] [Related]
16. Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists. Buck IM, Black JW, Cooke T, Dunstone DJ, Gaffen JD, Griffin EP, Harper EA, Hull RA, Kalindjian SB, Lilley EJ, Linney ID, Low CM, McDonald IM, Pether MJ, Roberts SP, Shankley NP, Shaxted ME, Steel KI, Sykes DA, Tozer MJ, Watt GF, Walker MK, Wright L, Wright PT. J Med Chem; 2005 Nov 03; 48(22):6803-12. PubMed ID: 16250639 [Abstract] [Full Text] [Related]
17. Optimization of 1,3,4-benzotriazepine-based CCK(2) antagonists to obtain potent, orally active inhibitors of gastrin-mediated gastric acid secretion. McDonald IM, Black JW, Buck IM, Dunstone DJ, Griffin EP, Harper EA, Hull RA, Kalindjian SB, Lilley EJ, Linney ID, Pether MJ, Roberts SP, Shaxted ME, Spencer J, Steel KI, Sykes DA, Walker MK, Watt GF, Wright L, Wright PT, Xun W. J Med Chem; 2007 Jun 28; 50(13):3101-12. PubMed ID: 17536796 [Abstract] [Full Text] [Related]
20. Anthranilic acid based CCK1 antagonists: the 2-indole moiety may represent a "needle" according to the recent homonymous concept. Varnavas A, Lassiani L, Valenta V, Berti F, Tontini A, Mennuni L, Makovec F. Eur J Med Chem; 2004 Jan 28; 39(1):85-97. PubMed ID: 14987837 [Abstract] [Full Text] [Related] Page: [Next] [New Search]